Welcome to ReachBio

ReachBio provides specialized contract assays, contract research, and educational and consulting services to biopharmaceutical, agrichemical and other life science organizations worldwide. Our focus is on helping our clients expand their organizations’ capabilities by efficiently harnessing our extensive knowledge and expertise in clinical and industrial stem cell and progenitor cell biology for their benefit. We operate strictly through a fee-for-service model in which the client owns all new intellectual property generated.

We offer a variety of standardized contract services based on functional in vitro and in vivo cell biology assays for bone marrow modulation, drug toxicity testing and mechanistic evaluation of various types of compounds. We also offer agrichemical and environmental toxicity assay design services that can be specifically tailored to meet your unique requirements. While most of our assays are performed in our own fully-equipped laboratory following Good Laboratory Practices, we also offer flexible on-site assay services upon request.

ReachBio's contract research and consulting services make our broad experience in stem cell biology, life science research products, business development and technology transfer available to a wide variety of clients, including: academic institutions, established life science research tools providers, start-up and virtual companies, cell therapy companies, government agencies, toxicity testing organizations, scientific and medical societies, venture capital and investment banking firms, etc.

For more information about ReachBio,

please click here.

What's New at ReachBio

ColonyGEL™  Methylcellulose-Based Media for CFC Assays – Mouse Formulations Now Available!

ReachBio ColonyGEL™ Media are made using pre-screened and carefully selected components to make our media reliable and reproducible. Our media meets or beats the current gold standard CFC media and is manufactured in the USA in accordance to GMP standards. We use the same media in our contract service labs for high value drug development applications.

Various optimized formulations are available for the growth of myeloid (CFU-GM, CFU-G, CFU-M), erythroid (BFU-E and CFU-E), and mixed (CFU-GEMM) colonies. Human Formulations Available in July 2010!

:: ColonyGEL™ 1201 Mouse Base Media Sample Request

:: ColonyGEL™ 1202 Complete Media Sample Request

Human Primary Hematopoietic Cells Now Available!

ReachBio now offers hematopoietic stem/progenitor cells from bone marrow, cord blood and mobilized peripheral blood, as well as, hematopoietic cell subsets from peripheral blood.

For a complete list of primary cells, please click here.